Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Diagnostics

Set Alert for Diagnostics

Zomedica raises $4.28m at close of offering

Zomedica Pharmaceuticals has closed its private offering and raised proceeds of $4.28 million.
Investments Diagnostics

Zomedica R&D boosted by development partner funding

Zomedica Pharmaceuticals' diagnostics development work is set to benefit from funding awarded to one of its R&D partners.

R&D Diagnostics

Review 2018: Smart M&A money is put on diagnostics and digital tech

In 2018, the stand-out M&A deals targeted diagnostics, digital technologies and nutrition. While Zoetis and Merck Animal Health made multi-billion-dollar deals, some of the sector's smaller purchases also hinted towards important trends. Animal Pharm editor Joseph Harvey looks back at where the money was spent.

M&A Abaxis

Review 2018: Two strategies for claiming vet diagnostics market share emerge

During 2018, there were a whole host of developments in the veterinary diagnostics market. Although this sector is relatively young and has a small number of dedicated players, it is receiving a lot of attention from animal health companies big and small. Animal Pharm editor Joseph Harvey investigates.

Diagnostics Abaxis

Zomedica targets 2020 launch for three diagnostics

Zomedica Pharmaceuticals plans to begin marketing three of its diagnostics in the US over the course of 2020.

Diagnostics Companion Animals

AniCon takes diagnostic products and custom vaccines expertise to wider European markets

German firm AniCon Labor is increasing its sales base for its veterinary diagnostic products and autogenous vaccines outside its domestic market.

Diagnostics Vaccines

Zoetis research director joins board of Xip Diagnostics

Melanie Winowiecki has joined the board of directors of Xip Diagnostics – a developer of analytical point-of-care tests for both human and animal health.

People Diagnostics

Heska gains ownership of Cuattro imaging software

Heska has purchased certain Cuattro digital imaging software and related assets.

Heska M&A

Zomedica further builds diagnostics pipeline with exclusive POC deal

US firm Zomedica Pharmaceuticals has brought new point-of-care (POC) diagnostic technology into its portfolio, following an exclusive deal with Qorvo Biotechnologies.

Diagnostics Deals

Animal Pharm, Stonehaven Consulting map out industry's innovative start-ups

A new collaborative report from Animal Pharm and Stonehaven Consulting has highlighted the leading start-up companies in the animal health space.

R&D Investments

Heska becomes long-term provider of diagnostics to Ethos

Heska has become the sole provider of point-of-care diagnostics and consumables to Ethos Veterinary Health.

Heska Diagnostics

Credo Biomedical aims to empower vets with POC diagnostic technology

Singapore-based Credo Biomedical is seeking global partners to take its point-of-care (POC) molecular diagnostics for companion animals to a wider sales base.

Equipment & Technology Companion Animals
See All
Advertisement
UsernamePublicRestriction

Register